[1] | Hoyert DL, Xu J (2012) Deaths: Preliminary Data for 2011, National Vital Statistics Reports 61.
|
[2] | The top 10 causes of death. Available: http://www.who.int/mediacentre/factsheet?s/fs310/en/. Accessed 2013 Dec. 18.
|
[3] | Frink RJ (2002) Inflammatory Atherosclerosis, Heart Research Foundation.
|
[4] | Moreno PR (2010) Vulnerable Plaque: Definition, Diagnosis, and Treatment. Cardiology Clinics 28: 1–30. doi: 10.1016/j.ccl.2009.09.008
|
[5] | Libby P, Ridker PM, Maseri A (2002) Inflammation and Atherosclerosis. Circulation 105: 1135–1143. doi: 10.1161/hc0902.104353
|
[6] | Cohen A, Myerscough MR, Thompson RS (2012) Athero-protective effects of High Density Lipoproteins (HDL): An ODE model of the early stages of atherosclerosis. Preprint doi: 10.1007/s11538-014-9948-4
|
[7] | McKay C, McKee S, Mottram N, Mulholland T, Wilson S (2005) Towards a model of atherosclerosis. Strathclyde Mathematics Research Report
|
[8] | Ryu BH (2000) Low Density Lipoprotein (LDL), Atherosclerosis and Antioxidants. Biotechnol. Bioprocess Eng 5: 313–319. doi: 10.1007/bf02942205
|
[9] | Harrington JR (2000) The Role of MCP-1 in Atherosclerosis. Stem Cells 18: 65–66. doi: 10.1634/stemcells.18-1-65
|
[10] | Reape TJ, Groot P (1999) Chemokines and atherosclerosis. Atherosclerosis 147: 213C225. doi: 10.1016/s0021-9150(99)00346-9
|
[11] | Osterud B, Bjorklid E (2003) Role of Monocytes in Atherogenesis. Physiol Rev 83: 1069–1112.
|
[12] | Gui T, Shimokado A, Sun Y, Akasaka T, Muragaki Y (2012) Diverse Roles ofMacrophages in Atherosclerosis: From Inflammatory Biology to Biomarker Discovery. Mediators of Inflammation 2012: ID693083. doi: 10.1155/2012/693083
|
[13] | Johnson JL, Newby AC (2009) Macrophage heterogeneity in atherosclerotic plaques. Curr Opin Lipidol 20: 370–378. doi: 10.1097/mol.0b013e3283309848
|
[14] | Little MP, Gola A, Tzoulaki I (2009) A Model of Cardiovascular Disease Giving a Plausible Mechanism for the Effect of Fractionated Low-Dose Ionizing Radiation Exposure. PLoS Computational Biology 5: e1000539. doi: 10.1371/journal.pcbi.1000539
|
[15] | Calvez V, Ebde A, Meunier N, Raoult A (2009) Mathematical modelling of the atherosclerotic plaque formation. CEMRACS 2008 - Modelling and Numerical Simulation of Complex Fluids 28: 1–12. doi: 10.1051/proc/2009036
|
[16] | Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, et al. (1990) Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 248: 1009–1012. doi: 10.1126/science.2343305
|
[17] | Raines EW, Ross R (1993) Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J 69: 30–37. doi: 10.1136/hrt.69.1_suppl.s30
|
[18] | Rodriguez JA, Orbe J, Paramo JA (2007) Metalloproteases, Vascular Remodeling, and Atherothrombotic Syndromes. Rev Esp Cardiol 60: 959–967. doi: 10.1157/13109649
|
[19] | Fabunmi RP, Sukhova GK, Sugiyama S, Libby P (1998) Expression of Tissue Inhibitor of Metalloproteinases-3 in Human Atheroma and Regulation in Lesion-Associated Cells A Potential Protective Mechanism in Plaque Stability. Circ Res 83: 270–278. doi: 10.1161/01.res.83.3.270
|
[20] | King IL, Segal BM (2005) Cutting edge: IL-12 induces CD4+CD25- T cell activation in the presence of T regulatory cells. J Immunol 175: 641–645. doi: 10.4049/jimmunol.175.2.641
|
[21] | Hansson GK, Holm J, Jonasson L (1989) Detection of activated T lymphocytes in the human atherosclerotic plaque, Am. J Pathol 135: 169–175.
|
[22] | Kosaka C, Masuda J, Shimokado K, Zen K, Yokota T, et al. (1992) Interferon-gamma suppresses PDGF production from THP-1 cells and blood monocyte-derived macrophages. Atherosclerosis 97: 75–87. doi: 10.1016/0021-9150(92)90053-j
|
[23] | Barter P (2005) The role of HDL-cholesterol in preventing atherosclerotic disease, European Heart Journal Supplements. 7: : 4–8.
|
[24] | Barter P, Brandrup-Wognsen G, Palmer M, Nicholls S (2010) Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database. J Lipid Res 51: 1546–1553. doi: 10.1194/jlr.p002816
|
[25] | Mayo Clinic Staff, Cholesterol levels: What numbers should you aim for? Available: http://www.mayoclinic.com/health/cholest?erol-levels/CL00001. Accessed 2013 Dec. 12.
|
[26] | Rahdert DA, Sweet WL, Tio FO, Janicki C, Duggan DM (1999) Measurement of density and calcium in human atherosclerotic plaque and implications for arterial brachytherapy. Cardiovasc Radiat Med 1: 358–367. doi: 10.1016/s1522-1865(00)00030-5
|
[27] | Orbe J, Rodriguez JA, Arias R (2003) Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: Implications for plaque stabilization. Atherosclerosis 167: 45–53. doi: 10.1016/s0021-9150(02)00392-1
|
[28] | Kim Y, Roh S, Lawler S, Friedman A (2011) miR and AMPK mutual antagonism in glioma cell migration and proliferation: a mathematical model. PLoS One 6: e28293. doi: 10.1371/journal.pone.0028293
|
[29] | Byrne HM (1997) The importance of intercellular adhesion in the development of carcinomas. IMA Journal of Mathematics Applied in Medicine & Biology 14: 305–323. doi: 10.1093/imammb/14.4.305
|
[30] | Byrne HM (1999) A weakly nonlinear analysis of a model of avascular solid tumour growth. J Math Biol 39: 59–89. doi: 10.1007/s002850050163
|
[31] | Byrne HM, Chaplain MA (1996) Modelling the role of cell-cell adhesion in the growth and development of carcinomas. Mathematical and Computer Modelling 24: 1–7. doi: 10.1016/s0895-7177(96)00174-4
|
[32] | Chothia C (1976) The nature of the accessible and buried surfaces in proteins. J Mol Biol 105: 1–12. doi: 10.1016/0022-2836(76)90191-1
|
[33] | Janin J, Chothia C (1978) Role of Hydrophobicity in the Binding of Coenzymes. Biochemistry 17: 2943–2948. doi: 10.1021/bi00608a001
|
[34] | Cobbold C, Sherratt J, Maxwell S (2002) Lipoprotein oxidation and its significance for atherosclerosis: a mathematical approach. Bulletin of Mathematical Biology 64: 65–95. doi: 10.1006/bulm.2001.0267
|
[35] | Ingold KU, Bowry VW, Stocker R, Walling C (1993) Autoxidation of lipids and antioxidation by a-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognised consequences of lipid particle size as exemplified by oxidation of human low density lipoprotein. Proc Natl Acad Sci 90: 45–49. doi: 10.1073/pnas.90.1.45
|
[36] | Kim Y, Lawler S, Nowicki M, Chiocca E, Friedman A (2009) A mathematical model for pattern formation of glioma cells outside the tumor spheroid core. J Theor Biol 260: 359–371. doi: 10.1016/j.jtbi.2009.06.025
|
[37] | Kim Y, Friedman A (2010) Interaction of tumor with its micro-environment: A mathematical model. Bull Math Biol 75: 1029–1068. doi: 10.1007/s11538-009-9481-z
|
[38] | Mercapide J, Cicco R, Castresana J, Klein-Szanto A (2003) 450 Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines. Int J Cancer 106: 676–682. doi: 10.1002/ijc.11286
|
[39] | Friedman A, Turner J, Szomolay B (2008) A model on the influence of age on immunity to infection with Mycobacterium tuberculosis. Exp Gerontol 43: 275–285. doi: 10.1016/j.exger.2007.12.004
|
[40] | Orme IM (1987) Aging and immunity to tuberculosis: increased susceptibility of old mice reflects a decreased capacity to generate mediator T lymphocytes. J Immunol 138: 4414–4418.
|
[41] | Barrett T, Benditt E (1988) Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall. Proc Natl Acad Sci 85: 2810–2814. doi: 10.1073/pnas.85.8.2810
|
[42] | Xue C, Friedman A, Sen CK (2009) A mathematical model of ischemic cutaneous wounds. Proc Natl Acad Sci 106: 16782–16787. doi: 10.1073/pnas.0909115106
|
[43] | Dollery CM, Libby P (2006) Atherosclerosis and proteinase activation. Cardiovascular Research 69: 625–635. doi: 10.1016/j.cardiores.2005.11.003
|
[44] | Chen D, Roda JM, Mash CB, Eubank TD, Friedman A (2012) Hypoxia inducible factors mediated-inhibition of cancer by GM-CSF: A mathematical model. Bulletin of Mathematical Biology 74: 2752–2777. doi: 10.1007/s11538-012-9776-3
|
[45] | Day J, Friedman A, Schlesinger LS (2009) Modeling the immune rheostat of macrophages in the lung in response to infection. Proc Natl Acad Sci 106: 11246–11251. doi: 10.1073/pnas.0904846106
|
[46] | Yamamoto S, Nguyen JH (2006) TIMP-1/MMP-9 imbalance in brain edema in rats with fulminant hepatic failure. J Surg Res 134: 307–314. doi: 10.1016/j.jss.2005.11.588
|
[47] | Olson MW, Gervasi DC, Mobashery S, Fridman R (1997) Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J Biol Chem 21: 29975–29983. doi: 10.1074/jbc.272.47.29975
|
[48] | Palosaari H, Yliopisto O (2003) Matrix Metalloproteinases (MMPs) and Their Specific Tissue Inhibitors (TIMPs) in Mature Human Odontoblasts and Pulp Tissue. Oulun yliopisto doi: 10.1034/j.1600-0722.2003.00026.x
|
[49] | Bofill M, Janossy G, Lee CA, MacDonald-Burns D, Phillips AN, et al. (1992) Laboratory 475 control values for CD4 and CD8 T lymphocytes Implications for HIV-1 diagnosis. Clin Exp Immunol 88: 243–252. doi: 10.1111/j.1365-2249.1992.tb03068.x
|
[50] | Persson PO, Strang G (2004) A Simple Mesh Generator in MATLAB. SIAM Review 46: 329–345. doi: 10.1137/s0036144503429121
|
[51] | Alberty J, Carstensen C, Funken SA (1999) Remarks around 50 lines of Matlab: short finite element implementation. Numerical Algorithms 20: 117–137. doi: 10.1023/a:1019155918070
|
[52] | Z Li. The finite element method for two dimensional problems. Chapter 9 Avialable http://www4.ncsu.edu/~zhilin/TEACHING/MA?587/chap9.pdf. Accessed 2013 Oct. 10.
|
[53] | Marino S, Hogue IB, Ray CJ, Kirschner DE (2008) A methodology for performing global uncertainty and sensitivity analysisin systems. J Theor Biol 254: 178–196. doi: 10.1016/j.jtbi.2008.04.011
|
[54] | Arsenault BJ, Rana JS, Stroes ES, Despres JP, Shah PK, et al. (2009) Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol 55: 35–41.
|
[55] | Mayo Clinic Staff, How important is cholesterol ratio? Available: http://www.mayoclinic.org/diseases-condi?tions/high-blood-cholesterol/expert-answ?ers/cholesterol-ratio/faq-20058006. Accessed 2013 Dec. 20.
|
[56] | Crestor Managing Choleserol. Available: http://www.crestor.com/c/your-arteries/t?ools-resources/index.aspx.
|
[57] | Otani H (2013) Site-Specific Antioxidative Therapy for Prevention of Atherosclerosis and Cardiovascular Disease. Oxid Med Cell Longev
|
[58] | Ozkanlar S, Akcay F (2012) Antioxidant vitamins in atherosclerosis–animal experiments and clinical studies. Adv Clin Exp Med 21: 115–123.
|
[59] | Tardif J (2005) Antioxidants and atherosclerosis: emerging drug therapies. Curr Atheroscler Rep 7: 71–77. doi: 10.1007/s11883-005-0078-1
|
[60] | Levonen A, Vahakangas E, Koponen JK, Herttuala S (2008) Antioxidant Gene Therapy for Cardiovascular Disease Current Status and Future Perspectives. Circulation 117: 2142–2150. doi: 10.1161/circulationaha.107.718585
|
[61] | Ishigaki Y, Oka Y, Katagiri H (2009) Circulating oxidized LDL: a biomarker and 501 a pathogenic factor. Curr Opin Lipidol 20: 363–369. doi: 10.1097/mol.0b013e32832fa58d
|
[62] | Tsimikas S, Witztum JL (2001) Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. Circulation 103: 1930–1932. doi: 10.1161/01.cir.103.15.1930
|
[63] | Rajman I, Eacho P, Chowienczyk P, Ritter J (1999) LDL particle size: an important drug target? Br J Clin Pharmacol 48: 125–133. doi: 10.1046/j.1365-2125.1999.00991.x
|
[64] | Hokland B, Mendez A, Oram J (1992) Cellular localization and characterization of proteins that bind high density lipoprotein. J Lipid Res 33: 1335–1342.
|
[65] | Mitsuhashi T, Ono K, Fukuda M, Hasegawa Y (2013) Free radical scavenging ability and structure of a 90-kDa protein from the scallop shell. Fisheries Science 79: 495–502. doi: 10.1007/s12562-013-0616-7
|
[66] | Garcia-Tunon I, Ricote M, Ruiz A, Fraile B, Paniagua R, et al. (2007) Influence of IFN-gamma and its receptors in human breast cancer. BMC Cancer 7: 158. doi: 10.1186/1471-2407-7-158
|
[67] | Antoniades H (1981) Human platelet-derived growth factor (PDGF): purification of PDGF-I and PDGF-II and separation of their reduced subunits. Proc Natl Acad Sci 78: 7314–7317. doi: 10.1073/pnas.78.12.7314
|
[68] | Yokochi S, Hashimoto H, Ishiwata Y, Shimokawa H, Haino M, et al. (2001) An Anti-Inflammatory Drug, Propagermanium, May Target GPI-Anchored Proteins Associated with an MCP-1 Receptor, CCR2. Journal of Interferon and Cytokine Research 21: 389–398. doi: 10.1089/107999001750277862
|
[69] | Hamza T, Barnett J, Li B (2010) Interleukin 12 a Key Immunoregulatory Cytokine in Infection Applications. Int J Mol Sci 11: 789–806. doi: 10.3390/ijms11030789
|
[70] | O'Keefe JH, Cordain L, Harris WH, Moe RM, Vogel R (2004) Optimal low-density lipoprotein is 50 to 70 mg/dl: lower is better and physiologically normal. Journal of the American College of Cardiology 43: 2142–2146. doi: 10.1016/j.jacc.2004.03.046
|
[71] | Miller DC, Thapa A, Haberstroh KM, Webster TJ (2004) Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features. Biomaterials 25: 53–61. doi: 10.1016/s0142-9612(03)00471-x
|
[72] | Bowen-Pope DF, Malpass TW, Foster DM, Ross R (1984) Platelet-derived growth factor in 526 vivo: levels, activity, and rate of clearance. Blood 64: 458–469.
|
[73] | Rhodes J, Sharkey J, Andrews P (2009) Serum IL-8 and MCP-1 concentration do not identify patients with enlarging contusions after traumatic brain injury. J Trauma 66: 1591–1597. doi: 10.1097/ta.0b013e31819a0344
|
[74] | Gattorno M, Picco P, Vignola S, Stalla F, Buoncompagni A, et al. (1998) Serum interleukin 12 concentration in juvenile chronic arthritis. Ann Rheum Dis 57: 425–428. doi: 10.1136/ard.57.7.425
|
[75] | Tietz NW (1999) Clinical Guide to Laboratory Tests. Philadelphia 3rd Ed.
|
[76] | Liao KL, Bai XF, Friedman A (2013) The role of CD200-CD200R in tumor immune evasion. J Theor Biol 328: 65–76. doi: 10.1016/j.jtbi.2013.03.017
|
[77] | Tsukaguchi K, Balaji KN, Boom WH (1995) CD4+ alpha beta T cell and gamma delta T cell responses to Mycobacterium tuberculosis. J Immunol 154: 1786–1796.
|